Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Protalix BioTherapeutics (PLX) Pension (2016 - 2025)

Historic Pension for Protalix BioTherapeutics (PLX) over the last 17 years, with Q3 2025 value amounting to $631000.0.

  • Protalix BioTherapeutics' Pension fell 1356.16% to $631000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $631000.0, marking a year-over-year decrease of 1356.16%. This contributed to the annual value of $559000.0 for FY2024, which is 2170.87% down from last year.
  • According to the latest figures from Q3 2025, Protalix BioTherapeutics' Pension is $631000.0, which was down 1356.16% from $615000.0 recorded in Q2 2025.
  • Protalix BioTherapeutics' Pension's 5-year high stood at $2.5 million during Q1 2022, with a 5-year trough of $551000.0 in Q1 2025.
  • Its 5-year average for Pension is $1.4 million, with a median of $1.6 million in 2023.
  • Per our database at Business Quant, Protalix BioTherapeutics' Pension surged by 1269.16% in 2021 and then plummeted by 5651.64% in 2023.
  • Protalix BioTherapeutics' Pension (Quarter) stood at $2.5 million in 2021, then tumbled by 33.58% to $1.6 million in 2022, then plummeted by 56.52% to $714000.0 in 2023, then decreased by 21.71% to $559000.0 in 2024, then grew by 12.88% to $631000.0 in 2025.
  • Its Pension was $631000.0 in Q3 2025, compared to $615000.0 in Q2 2025 and $551000.0 in Q1 2025.